CMO eyes clinical trials; BearingPoint, Bovis Lend Lease target Emerald Isle;

> New York contract manufacturer Norwich Pharmaceuticals has invested in the infrastructure, controls and specialized equipment necessary for pilot-scale formulation and the manufacture of clinical trial materials. Announcement

> Tech consultancy BearingPoint and construction management company Bovis Lend Lease have teamed to support the pharmaceutical and medical technology sectors in Ireland. Release

> Shanghai-based WuXi PharmaTech has named Wei-Min Chang has been appointed Vice President of Operations and General Manager of the company's SynTheAll manufacturing facility, where it makes active pharmaceutical ingredients and advanced intermediates for use in preclinical and clinical trials. The company recently completed construction of an expanded facility, known as SynTheAll Phase 2, to produce advanced intermediates and APIs for late-stage clinical trials and commercial supplies. Release

> A mid- to high-level production double-sided tablet press boasts 49 stations, touch-screen controls, automatic weight control and removable turret capabilities. Article

Suggested Articles

In a first, the FDA and Indian oversight agencies worked together to block illegal drugs from entering the U.S. 

After months of delay for ultra-pricey gene therapy Zynteglo, Bluebird Bio is hoping to dose its first German patients in the first half of the year.

North Carolina is providing some financial assistance for the construction of Audentes gene therapy facility in Sanford, North Carolina. (Astellas)